Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-16-125329
Filing Date
2016-09-26
Accepted
2016-09-26 16:31:48
Documents
39
Period of Report
2016-09-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v449131_6-k.htm 6-K 12282
2 EXHIBIT 99.1 v449131_ex99-1.htm EX-99.1 176600
3 EXHIBIT 99.2 v449131_ex99-2.htm EX-99.2 154060
10 GRAPHIC image_001.jpg GRAPHIC 51638
  Complete submission text file 0001144204-16-125329.txt   1705281

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rosg-20160630.xml EX-101.INS 160089
5 XBRL TAXONOMY EXTENSION SCHEMA rosg-20160630.xsd EX-101.SCH 21081
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rosg-20160630_cal.xml EX-101.CAL 39932
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rosg-20160630_def.xml EX-101.DEF 51791
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rosg-20160630_lab.xml EX-101.LAB 235389
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rosg-20160630_pre.xml EX-101.PRE 129091
Mailing Address 10 PLAUT STREET, SCIENCE PARK POB 4059 REHOVOT L3 76706
Business Address 10 PLAUT STREET, SCIENCE PARK POB 4059 REHOVOT L3 76706 972-73-222-0700
Rosetta Genomics Ltd. (Filer) CIK: 0001362959 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-33042 | Film No.: 161902553
SIC: 2834 Pharmaceutical Preparations